Gout

Hyperuricemia is bidirectionally linked to insulin resistance. Insulin resistance inhibits the excretion of uric acid by the kidneys, and high uric acid levels exacerbate insulin resistance through endothelial dysfunction and oxidative stress. This vicious cycle constitutes metabolic syndrome, along with hypertension, type 2 diabetes, dyslipidemia, and abdominal obesity. Numerous studies indicate that patients with gout have a higher risk of myocardial infarction and stroke than the general population. Therefore, blood pressure, blood sugar, and lipid profiles must also be managed during gout treatment. In Korean traditional medicine, gout, hypertension, diabetes, and hyperlipidemia are all connected in that impaired digestive and kidney function, along with sticky waste products and stagnant blood, act as common disease mechanisms. When digestive function is weak and transport is impaired, sticky waste products are generated; these waste products cloud the blood, leading to blood stagnation and affecting the cardiovascular and metabolic systems as a whole. At Dongjedang, we approach the treatment not as a standalone treatment for gout, but from the perspective of improving the entire metabolic environment. We provide integrated management of gout and its associated conditions through prescriptions that reduce waste products by restoring digestive function, normalize water metabolism by reinforcing kidney energy, and support vascular health by clearing stagnant blood.